A gene expression signature of Retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer.
Oncotarget 2016 Sep 7 (42): 68012-68022.
Malorni Luca, Piazza Silvano, Ciani Yari, Guarducci Cristina, Bonechi Martina, Biagioni Chiara, Hart Christopher D, Verardo Roberto, Di Leo Angelo, Migliaccio Ilen
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: